で公開中です! 詳しく見る
IRTCのアイコン

iRhythm Holdings

108.66 USD
-0.69
0.63%
終値時点 更新済み 10月16日 16:00 EDT
プレマーケット
時間外取引
108.66
0.00
0%
1日
-0.63%
5日間
1.44%
1か月
-2.83%
3か月
-5.8%
6か月
-11.38%
年初来
-37.99%
1年
-39.97%
5年間
54.81%
10年間
317.12%
 

概要: iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

従業員数: 2,400

ニュース

ポジティブ
ニュートラル
ネガティブ
センチメント 3か月間
ポジティブ 39.1%
ニュートラル 60.9%
ネガティブ 0%
ニュートラル
GlobeNewsWire
昨日
iRhythm Holdings to Report Third Quarter 2026 Financial Results on November 5, 2026
SAN FRANCISCO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will release financial results for the third quarter 2026 after the close of trading on Thursday, November 5, 2026. The company's management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.
iRhythm Holdings to Report Third Quarter 2026 Financial Results on November 5, 2026
ニュートラル
PRNewsWire
3 日前
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
ニュートラル
GlobeNewsWire
10 日前
iRhythm Holdings Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Patient Data Is Exposed
Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from a reported data breach at iRhythm Holdings, Inc.
iRhythm Holdings Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Patient Data Is Exposed
ニュートラル
GlobeNewsWire
11 日前
iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care
SAN FRANCISCO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (Nasdaq: IRTC) today announced that it completed the previously announced acquisition of Vital Connect, Inc. ("VitalConnect"), a leader in wearable biosensor technology and ambulatory cardiac monitoring.
iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care
ニュートラル
GlobeNewsWire
14 日前
iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026
Following completion of the forensic investigation, company begins notifying impacted individuals Following completion of the forensic investigation, company begins notifying impacted individuals
iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026
ニュートラル
GlobeNewsWire
19 日前
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
NEW YORK, Sept. 27, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of  iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders.
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
ポジティブ
Zacks Investment Research
24 日前
Here's Why You Should Retain IRTC Stock in Your Portfolio for Now
iRhythm's Q2 momentum, AI-driven predictive care and deeper EHR integration support growth, though reimbursement pressures remain.
Here's Why You Should Retain IRTC Stock in Your Portfolio for Now
ポジティブ
Zacks Investment Research
先月
Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated?
iRhythm's Q2 revenue growth, margin expansion and record free cash flow strengthen its case, but reimbursement and regulatory risks remain elevated.
Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated?
ニュートラル
GlobeNewsWire
先月
iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference
SAN FRANCISCO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will participate in the upcoming Wells Fargo 21st Annual Healthcare Conference.
iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference
ポジティブ
Seeking Alpha
先月
iRhythm: The Algorithmic Margin Inflection Changes The Story
iRhythm Technologies is evolving from a cardiac patch producer to a comprehensive cardiac monitoring platform, leveraging software and workflow integration for a competitive advantage. Q2 2026 marked a financial inflection: 20.1% revenue growth, 72.8% gross margin, and adjusted EBITDA margin expansion to 19.3%, with raised full-year guidance and record free cash flow. The ZEUS platform's FDA clearance enables significant margin leverage, reducing clinician review time by 50% and targeting $100 million in cost savings over five years.
iRhythm: The Algorithmic Margin Inflection Changes The Story
価格チャートは Lightweight Charts™ を使用して実装されています